|
1
|
Maiorano D, Lutzmann M and Mechali M: MCM
proteins and DNA replication. Curr Opin Cell Biol. 18:130–136.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Forsburg SL: Eukaryotic MCM proteins:
Beyond replication initiation. Microbiol Mol Biol Rev. 68:109–131.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee JK and Hurwitz J: Isolation and
characterization of various complexes of the minichromosome
maintenance proteins of Schizosaccharomyces pombe. J Biol Chem.
275:18871–18878. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Takei Y and Tsujimoto G: Identification of
a novel MCM3-associated protein that facilitates MCM3 nuclear
localization. J Biol Chem. 273:22177–22180. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Stewart PA, Khamis ZI, Zhau HE, Duan P, Li
Q, Chung LWK and Sang QA: Upregulation of minichromosome
maintenance complex component 3 during epithelial-to-mesenchymal
transition in human prostate cancer. Oncotarget. 8:39209–39217.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mulvaney KM, Matson JP, Siesser PF, Tamir
TY, Goldfarb D, Jacobs TM, Cloer EW, Harrison JS, Vaziri C, Cook JG
and Major MB: Identification and characterization of MCM3 as a
Kelch-like ECH-associated protein 1 (KEAP1) substrate. J Biol Chem.
291:23719–23733. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guo J, Ma Z, Ma Q, Wu Z, Fan P, Zhou X,
Chen L, Zhou S, Goltzman D, Miao D and Wu E: 1, 25(OH)2D3 inhibits
hepatocellular carcinoma development through reducing secretion of
inflammatory cytokines from immunocytes. Curr Med Chem.
20:4131–4141. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu D, Staveley-O'Carroll KF and Li G:
Immune-based therapy clinical trials in hepatocellular carcinoma. J
Clin Cell Immunol. 6:3762015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim HS and El-Serag HB: The epidemiology
of hepatocellular carcinoma in the USA. Curr Gastroenterol Rep.
21:172019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Cui J, Zhou XD, Liu YK, Tang ZY and Zile
MH: Abnormal beta-catenin gene expression with invasiveness of
primary hepatocellular carcinoma in China. World J Gastroenterol.
7:542–546. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ishibashi Y, Kinugasa T, Akagi Y, Ohchi T,
Gotanda Y, Tanaka N, Fujino S, Yuge K, Kibe S, Yoshida N, et al:
Minichromosome maintenance protein 7 is a risk factor for
recurrence in patients with Dukes C colorectal cancer. Anticancer
Res. 34:4569–4575. 2014.PubMed/NCBI
|
|
12
|
Kato K, Toki T, Shimizu M, Shiozawa T,
Fujii S, Nikaido T and Konishi I: Expression of
replication-licensing factors MCM2 and MCM3 in normal,
hyperplastic, and carcinomatous endometrium: Correlation with
expression of Ki-67 and estrogen and progesterone receptors. Int J
Gynecol Pathol. 22:334–340. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lau KM, Chan QK, Pang JC, Li KK, Yeung WW,
Chung NY, Lui PC, Tam YS, Li HM, Zhou L, et al: Minichromosome
maintenance proteins 2, 3 and 7 in medulloblastoma: Overexpression
and involvement in regulation of cell migration and invasion.
Oncogene. 29:5475–5489. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chevalier S and Blow JJ: Cell cycle
control of replication initiation in eukaryotes. Curr Opin Cell
Biol. 8:815–821. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Carreon-Burciaga RG, Gonzalez-Gonzalez R,
Molina-Frechero N and Bologna-Molina R: Immunoexpression of Ki-67,
MCM2, and MCM3 in ameloblastoma and ameloblastic carcinoma and
their correlations with clinical and histopathological patterns.
Dis Markers. 2015:6830872015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou L, Wang SB, Chen SG, Qu Q and Rui JA:
Prognostic value of ALT, AST, and AAR in hepatocellular carcinoma
with B-Type hepatitis-associated cirrhosis after radical
hepatectomy. Clin Lab. 64:1739–1747. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bi X, Yan T, Zhao H, Zhao J, Li Z, Huang
Z, Zhou J and Cai J: Correlation of alpha fetoprotein with the
prognosis of hepatocellular carcinoma after hepatectomy in an
ethnic Chinese population. Zhonghua Yi Xue Za Zhi. 94:2645–2649.
2014.(In Chinese). PubMed/NCBI
|
|
18
|
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH,
Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, et al: Guidelines for
diagnosis and treatment of primary liver cancer in China (2017
edition). Liver Cancer. 7:235–260. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhou L, Rui JA, Zhou WX, Wang SB, Chen SG
and Qu Q: Edmondson-Steiner grade: A crucial predictor of
recurrence and survival in hepatocellular carcinoma without
microvascular invasio. Pathol Res Pract. 213:824–830. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Shi K, Wang SL, Shen B, Yu FQ, Weng DF and
Lin JH: Clinicopathological and prognostic values of fibronectin
and integrin alphavbeta3 expression in primary osteosarcoma. World
J Surg Oncol. 17:232019. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bader G and Hogue C: An automated method
for finding molecular complexes in large protein interaction
networks. BMC Bioinformatics. 4:22003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cai C, Wang W and Tu Z: Aberrantly DNA
methylated-differentially expressed genes and pathways in
hepatocellular carcinoma. J Cancer. 10:355–366. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Korner T, Kropf J, Kosche B, Kristahl H,
Jaspersen D and Gressner AM: Improvement of prognostic power of the
Child-Pugh classification of liver cirrhosis by hyaluronan. J
Hepatol. 39:947–953. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stead BE, Sorbara CD, Brandl CJ and Davey
MJ: ATP binding and hydrolysis by Mcm2 regulate DNA binding by Mcm
complexes. J Mol Biol. 391:301–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhuang L, Yang Z and Meng Z: Upregulation
of BUB1B, CCNB1, CDC7, CDC20, and MCM3 in tumor tissues predicted
worse overall survival and disease-Free survival in hepatocellular
carcinoma patients. Biomed Res Int. 2018:78973462018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liao X, Liu X, Yang C, Wang X, Yu T, Han
C, Huang K, Zhu G, Su H, Qin W, et al: Distinct diagnostic and
prognostic values of minichromosome maintenance gene expression in
patients with hepatocellular carcinoma. J Cancer. 9:2357–2373.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu Y, Zhang Y, Zhao Y, Gao D, Xing J and
Liu H: High PARP-1 expression is associated with tumor invasion and
poor prognosis in gastric cancer. Oncol Lett. 12:3825–3835. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chatterjee D, Rashid A, Wang H, Katz MH,
Wolff RA, Varadhachary GR, Lee JE, Pisters PW, Gomez HF, Abbruzzese
JL, et al: Tumor invasion of muscular vessels predicts poor
prognosis in patients with pancreatic ductal adenocarcinoma who
have received neoadjuvant therapy and pancreaticoduodenectomy. Am J
Surg Pathol. 36:552–559. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hong SM, Pawlik TM, Cho H, Aggarwal B,
Goggins M, Hruban RH and Anders RA: Depth of tumor invasion better
predicts prognosis than the current American Joint Committee on
Cancer T classification for distal bile duct carcinoma. Surgery.
146:250–257. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bi XW, Zhang WW, Li ZM, Huang JJ, Xia Y,
Sun P, Wang Y and Jiang WQ: The extent of local tumor invasion
predicts prognosis in stage IE nasal natural killer/T-cell
lymphoma: A novel T staging system for risk stratification. Ann
Hematol. 94:1515–1524. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fan J, Tang ZY, Wu ZQ, Zhou J, Zhou XD, Ma
ZC, Qin LX, Qiu SJ, Yu Y and Huang C: The effects of portal vein
microscopic and macroscopic tumor thrombi on post-operation
patients with hepatocellular carcinoma. Zhonghua Wai Ke Za Zhi.
43:433–435. 2005.(In Chinese). PubMed/NCBI
|
|
33
|
Ryu S and Driever W: Minichromosome
maintenance proteins as markers for proliferation zones during
embryogenesis. Cell Cycle. 5:1140–1142. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lei M: The MCM complex: Its role in DNA
replication and implications for cancer therapy. Curr Cancer Drug
Targets. 5:365–380. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chuang CH, Yang D, Bai G, Freeland A,
Pruitt SC and Schimenti JC: Post-transcriptional homeostasis and
regulation of MCM2-7 in mammalian cells. Nucleic Acids Res.
40:4914–4924. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Juríková M, Danihel Ľ, Polák Š and Varga
I: Ki67, PCNA, and MCM proteins: Markers of proliferation in the
diagnosis of breast cancer. Acta Histochem. 118:544–552. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hua C, Zhao G, Li Y and Bie L:
Minichromosome Maintenance (MCM) Family as potential diagnostic and
prognostic tumor markers for human gliomas. BMC Cancer. 14:5262014.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cheng DD, Zhang HZ, Yuan JQ, Li SJ, Yang
QC and Fan CY: Minichromosome maintenance protein 2 and 3 promote
osteosarcoma progression via DHX9 and predict poor patient
prognosis. Oncotarget. 8:26380–26393. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Yu J, Xu QG, Wang ZG, Yang Y, Zhang L, Ma
JZ, Sun SH, Yang F and Zhou WP: Circular RNA cSMARCA5 inhibits
growth and metastasis in hepatocellular carcinoma. J Hepatol.
68:1214–1227. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cao S, Sun R, Wang W, Meng X, Zhang Y,
Zhang N and Yang S: RNA helicase DHX9 may be a therapeutic target
in lung cancer and inhibited by enoxacin. Am J Transl Res.
9:674–682. 2017.PubMed/NCBI
|
|
41
|
Mi J, Ray P, Liu J, Kuan CT, Xu J, Hsu D,
Sullenger BA, White RR and Clary BM: In vivo selection against
human colorectal cancer xenografts identifies an aptamer that
targets RNA helicase protein DHX9. Mol Ther Nucleic Acids.
5:e3152016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lee T, Paquet M, Larsson O and Pelletier
J: Tumor cell survival dependence on the DHX9 DExH-box helicase.
Oncogene. 35:5093–5105. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fidaleo M, Svetoni F, Volpe E, Minana B,
Caporossi D and Paronetto MP: Genotoxic stress inhibits Ewing
sarcoma cell growth by modulating alternative pre-mRNA processing
of the RNA helicase DHX9. Oncotarget. 6:31740–31757. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhang Y and Hunter T: Roles of Chk1 in
cell biology and cancer therapy. Int J Cancer. 134:1013–1023. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jin H, Xu G, Zhang Q, Pang Q and Fang M:
Synaptotagmin-7 is overexpressed in hepatocellular carcinoma and
regulates hepatocellular carcinoma cell proliferation via Chk1-p53
signaling. Onco Targets Ther. 10:4283–4293. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hong J, Hu K, Yuan Y, Sang Y, Bu Q, Chen
G, Yang L, Li B, Huang P, Chen D, et al: CHK1 targets spleen
tyrosine kinase (L) for proteolysis in hepatocellular carcinoma. J
Clin Invest. 122:2165–2175. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Han X, Mayca Pozo F, Wisotsky JN, Wang B,
Jacobberger JW and Zhang Y: Phosphorylation of minichromosome
maintenance 3 (MCM3) by checkpoint kinase 1 (Chk1) negatively
regulates DNA replication and checkpoint activation. J Biol Chem.
290:12370–12378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kitao H, Iimori M, Kataoka Y, Wakasa T,
Tokunaga E, Saeki H, Oki E and Maehara Y: DNA replication stress
and cancer chemotherapy. Cancer Sci. 109:264–271. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Xu D, Su C, Sun L, Gao Y and Li Y:
Performance of serum glypican 3 in diagnosis of hepatocellular
carcinoma: A meta-analysis. Ann Hepatol. 18:58–67. 2018. View Article : Google Scholar
|
